Key Highlights
- JPMorgan elevated IBM to Overweight from Neutral, increasing price target from $270 to $291
- Shares climbed over 4% to approximately $263 despite broader market weakness
- Software segment represents ~45% of revenue but generates nearly two-thirds of total profits
- Trump signed dual executive orders supporting quantum computing development, with IBM CEO in attendance
- Company committed $10 billion to quantum initiatives over five-year period; second-quarter results scheduled for July 22
International Business Machines experienced a notably positive trading session Tuesday, driven by two significant developments.
International Business Machines Corporation, IBM
Brian Essex, analyst at JPMorgan, elevated his rating on IBM shares to Overweight from a prior Neutral stance while simultaneously boosting his price objective to $291 from $270. The equity responded enthusiastically, advancing more than 4% to reach approximately $263.20, bucking the trend as Nasdaq futures declined 2.66% and S&P 500 futures retreated 1.30%.
Essex’s investment thesis centers on a straightforward premise: IBM’s software operations serve as the primary value driver, with its significance continuing to expand. While software represents approximately 45% of total revenue, it contributes nearly two-thirds of overall profitability. As artificial intelligence adoption accelerates, Essex anticipates this favorable revenue composition will continue trending toward higher-margin software.
The technology giant has executed approximately 50 strategic acquisitions during the past five years to strengthen this transition, notably including the significant Confluent acquisition completed in March. While some market observers have raised concerns about acquisition velocity and capital deployment, Essex contends that aggressive software investment today will diminish future capital requirements while simultaneously transitioning the revenue base toward predictable subscription models.
The analyst additionally highlighted potential valuation expansion opportunities should IBM establish itself as a credible AI infrastructure provider or deliver ahead of expectations on quantum computing commercialization.
Presidential Endorsement for Quantum Initiatives
The analyst upgrade represented only one of two catalysts. On Monday, President Trump executed two separate executive orders focused on quantum technology advancement — the first establishing a mandate to develop a research-grade quantum computer by 2028, while the second accelerates federal transition to post-quantum cryptographic standards by 2031.
Arvind Krishna, IBM’s Chief Executive Officer, participated in the Oval Office signing ceremony. Trump subsequently expressed regret about divesting his IBM holdings prematurely. Such visible executive branch support provides meaningful tailwinds.
IBM partnered with the Commerce Department earlier this year on a $1 billion joint commitment to construct Anderon, a dedicated quantum foundry facility. The company subsequently announced an additional $10 billion commitment toward quantum research and production capabilities spanning the next five years.
Essex observed that IBM has already captured more than $1.1 billion in quantum customer commitments since 2017 and surpassed $1 billion in cumulative quantum-related revenue. He views the company as strategically positioned within what he characterizes as a “meaningful total addressable market” for quantum computing applications.
IBM’s internal roadmap targets delivery of its most advanced quantum system, Starling, by 2029. Essex suggested any acceleration of this development timeline “could result in upside” to his current financial projections.
Street Sentiment Remains Constructive
IBM has accumulated increasingly positive analyst coverage. Barclays launched coverage at Buy earlier this month establishing a $350 price objective, while Citigroup maintains a Buy recommendation with a $375 target. Wedbush carries an Outperform rating alongside a $320 price target.
On Monday, IBM announced participation in OpenAI’s Daybreak Cyber Partner Program while unveiling a new AI-enhanced application security offering designed to help enterprises identify and remediate software vulnerabilities more efficiently.
The service leverages OpenAI’s technology to analyze code, rank critical security flaws by severity, and map potential exploitation vectors. This builds upon Project Lightwell, IBM’s $5 billion collaboration with Red Hat centered on software supply chain security enhancement.
IBM will report second-quarter financial results on July 22. Consensus analyst estimates call for earnings per share of $3.00, representing growth from $2.80 in the year-ago period, on revenue of $17.85 billion compared to $16.98 billion in the corresponding prior-year quarter.


